CompletedNot Applicable

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

United States18 participantsStarted 2022-12-01

Plain-language summary

Access to Syringes at Pharmacies (ASAP) is a refinement of an evidence-based, pharmacy intervention to increase pharmacy-based sales of syringes to PWID in order to reduce bloodborne illnesses among them.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * full time pharmacy staff member as a pharmacist or a pharmacy technician in an Arizona pharmacy within the three study counties (Pima, Maricopa, Mohave) Exclusion Criteria: * not a full time pharmacy staff member

What they're measuring

Syringe sales increase as measured by the sales tracking instrument

Timeframe: by end of year 2

Reduced stigma as measured by the feasibility assessment tool

Timeframe: by end of year 2

Trial details

NCT IDNCT05270135

SponsorUniversity of Arizona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Skin and Soft Tissue Infections trials